Breast cancer vaccines : Promise for the future or pipe dream?MITTENDORF, Elizabeth A; PEOPLES, George E; SINGLETARY, S. Eva et al.Cancer. 2007, Vol 110, Num 8, pp 1677-1686, issn 0008-543X, 10 p.Article

Predictive Model of Outcome of Targeted Nodal Assessment in Colorectal CancerNISSAN, Aviram; PROTIC, Mladjan; BILCHIK, Anton et al.Annals of surgery. 2010, Vol 251, Num 2, pp 265-274, issn 0003-4932, 10 p.Article

Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8⁺ cells recognizing HER2/neu vaccine peptidesMITTENDORF, Elizabeth A; STORRER, Catherine E; SHRIVER, Craig D et al.Breast cancer research and treatment. 2005, Vol 92, Num 1, pp 85-93, issn 0167-6806, 9 p.Article

United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) Randomized Controlled Trial Comparing Targeted Nodal Assessment and Ultrastaging With Standard Pathological Evaluation for Colon CancerNISSAN, Aviram; PROTIC, Mladjan; BILCHIK, Anton J et al.Annals of surgery. 2012, Vol 256, Num 3, pp 412-424, issn 0003-4932, 13 p.Conference Paper

Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patientsDEHQANZADA, Zia A; STORRER, Catherine E; HUEMAN, Matthew T et al.Clinical cancer research. 2006, Vol 12, Num 2, pp 478-486, issn 1078-0432, 9 p.Article

Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancerMITTENDORF, Elizabeth A; GURNEY, Jennifer M; STORRER, Catherine E et al.Surgery. 2006, Vol 139, Num 3, pp 407-418, issn 0039-6060, 12 p.Article

Clinical studies of vaccines targeting breast cancerKO, Byung K; KAWANO, Kouichiro; MURRAY, James L et al.Clinical cancer research. 2003, Vol 9, Num 9, pp 3222-3234, issn 1078-0432, 13 p.Article

Colorectal, Prostate, and Skin Cancer Screening Among Hispanic and White Non-Hispanic Men, 2000-2005JING ZHOU; ENEWOLD, Lindsey; PEOPLES, George E et al.Journal of the National Medical Association. 2011, Vol 103, Num 4, pp 343-350, issn 0027-9684, 8 p.Article

Distinct Patient Responses to Activation of T-cells by Free HER-2, G89 (777-789) and Protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} Peptides Could Lead to Development of Personalized Cancer VaccinesYUFENG LI; MATSUEDA, Satoko; EFFERSON, Clayton L et al.Anticancer research. 2009, Vol 29, Num 1, pp 41-58, issn 0250-7005, 18 p.Article

Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients : U.S. Military Cancer Institute Clinical Trials Group Study 1-01 and 1-02PEOPLES, George E; HOLMES, Jarrod P; STORRER, Catherine E et al.Clinical cancer research. 2008, Vol 14, Num 3, pp 797-803, issn 1078-0432, 7 p.Article

Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex® technologyDEHQANZADA, Zia A; STORRER, Catherine E; HUEMAN, Matthew T et al.Oncology reports. 2007, Vol 17, Num 3, pp 687-694, issn 1021-335X, 8 p.Article

Sensitivity of undifferentiated, high-TCR density CD8⁺ cells to methylene groups appended to tumor antigen determines their differentiation or deathKAWANO, Kouichiro; EFFERSON, Clay L; PEOPLES, George E et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2930-2937, issn 0008-5472, 8 p.Article

Clinical and Immunologic Responses of HLA-A3⁺ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical TrialPATIL, Ritesh; CLIFTON, Guy T; HOLMES, Jarrod P et al.Journal of the American College of Surgeons. 2010, Vol 210, Num 2, pp 140-147, issn 1072-7515, 8 p.Article

Cancer Incidence in the U.S. Military Population: Comparison with Rates from the SEER ProgramKANGMIN ZHU; DEVESA, Susan S; MCGLYNN, Katherine A et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 6, pp 1740-1745, issn 1055-9965, 6 p.Article

Prospective Trial Evaluating Electrical Impédance Scanning of Thyroid Nodules Before Thyroidectomy : Final ResultsNISSAN, Aviram; PEOPLES, George E; BURCH, Henry B et al.Annals of surgery. 2008, Vol 247, Num 5, pp 843-853, issn 0003-4932, 11 p.Article

Optimal Dose and Schedule of an HER-2/neu (E75) Peptide Vaccine to Prevent Breast Cancer Recurrence : From US Military Cancer Institute Clinical Trials Group Study 1-01 and 1-02HOLMES, Jarrod P; GATES, Jeremy D; PEOPLES, George E et al.Cancer. 2008, Vol 113, Num 7, pp 1666-1675, issn 0008-543X, 10 p.Article

Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patientsPEOPLES, George E; GURNEY, Jennifer M; HUEMAN, Matthew T et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7536-7545, issn 0732-183X, 10 p.Article

Thyroid Cancer Incidence among Active Duty U.S. Military Personnel, 1990―2004ENEWOLD, Lindsey R; JING ZHOU; MCGLYNN, Katherine A et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 11, pp 2369-2376, issn 1055-9965, 8 p.Article

Use of Booster Inoculations to Sustain the Clinical Effect of an Adjuvant Breast Cancer Vaccine: From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02HOLMES, Jarrod P; CLIFTON, Guy T; PATIL, Ritesh et al.Cancer. 2011, Vol 117, Num 3, pp 463-471, issn 0008-543X, 9 p.Article

Circulating regulatory T cells (CD4⁺CD25⁺FOXP3⁺) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptideGATES, Jeremy D; CLIFTON, Guy T; CIANO, Kathy et al.Vaccine. 2010, Vol 28, Num 47, pp 7476-7482, issn 0264-410X, 7 p.Article

N-Terminally LRMK-linked HER-2 peptides, AE-37 [p776(774-788)] and AE-47 [Ava-F7(776-788)], Aid Differentiation of E75-TCR⁺CD8⁺ Cells to Perforin-positive CellsMATSUEDA, Satoko; HUI GAO; EFFERSON, Clayton L et al.Anticancer research. 2009, Vol 29, Num 7, pp 2427-2435, issn 0250-7005, 9 p.Article

Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005ENEWOLD, Lindsey; KANGMIN ZHU; RON, Elaine et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 3, pp 784-791, issn 1055-9965, 8 p.Article

Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: Results from the United States military cancer institute clinical trials group study GI-01STOJADINOVIC, Alexander; NISSAN, Aviram; GRINBAUM, Ronit et al.Annals of surgery. 2007, Vol 245, Num 6, pp 846-857, issn 0003-4932, 12 p.Article

Shock wave therapy for acute and chronic soft tissue wounds : A feasibility studySCHADEN, Wolfgang; THIELE, Richard; KOLPI, Christine et al.The Journal of surgical research. 2007, Vol 143, Num 1, pp 1-12, issn 0022-4804, 12 p.Conference Paper

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trialMITTENDORF, Elizabeth A; STORRER, Catherine E; FOLEY, Rebecca J et al.Cancer. 2006, Vol 106, Num 11, pp 2309-2317, issn 0008-543X, 9 p.Article